FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Researchers at the Max Planck Institute found that obesity, characterized by reduced insulin sensitivity, impairs the brain’s associative learning capability.
Read MoreOctober 04, 2023 2 min read Source/Disclosures Published by: Disclosures: Davy-Mendez reports no relevant financial disclosures. Please see the study
Read MoreThe federal agency that oversees Social Security announced Wednesday that it will review the way it handles “overpayments” — money
Read MoreOctober 04, 2023 2 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on
Read MoreAt the European Association for the Study of Diabetes Annual Meeting, Prof. Matthias Blüher will discus the concept of metabolically
Read MoreExhibit from court record: 2018 Red Ferrari Spider. Source: U.S. DOJ A Miami federal judge ordered a lab owner convicted
Read MoreCLARKSVILLE, Tenn. — On a hot July morning, customers at the Dollar General along a two-lane highway northwest of Nashville
Read MoreOctober 02, 2023 4 min read Source/Disclosures Source: Healio Interviews Disclosures: Cleary reports no relevant financial disclosures. ADD TOPIC TO
Read MoreOctober 02, 2023 1 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on
Read MoreA vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. Dado Ruvic | Reuters
Read More